Home/Veraxa Biotech/Rick Austin, Ph.D.
RA

Rick Austin, Ph.D.

CSO

Veraxa Biotech

Therapeutic Areas

Veraxa Biotech Pipeline

DrugIndicationPhase
Lead Program (unspecified)Acute Myeloid Leukemia (AML)Phase 1